Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Receptos announces issuance of composition of matter patents covering proprietary lead product candidate RPC1063
Fatal Acute Myeloid Leukemia With 11q23 MLL Gene Rearrangement Following Mitoxantrone Treatment in a Case of Childhood-onset Multiple Sclerosis.
Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.
Testing for urinary tract colonisation before high-dose corticosteroid treatment in acute multiple sclerosis relapses: prospective algorithm validation.
Daclizumab Therapy for Multiple Sclerosis.
Toxicity of Teriflunomide in Aryl Hydrocarbon Receptor Deficient Mice.
First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models.
A novel pH-sensitive interferon-β (INF-β) oral delivery system for application in multiple sclerosis.
The correlation between symptomatic fatigue to definite measures of gait in people with multiple sclerosis.
BTG plc Close Period Update
Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging
Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis (ITT-PMS)
Arzerra
Efficacy and Tolerability of BAF312 in Patients With Polymyositis
Th17 cells: A prognostic marker for MS rebound after natalizumab cessation?
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS) (INSPIRE)
IgE-Mediated Allergic Reactions after the First Administration of Glatiramer Acetate in Patients with Multiple Sclerosis.
Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial.
Impact of sleep disorder treatment on fatigue in multiple sclerosis.
Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
Minocycline inhibits antigen processing for presentation to human T cells: additive inhibition with chloroquine at therapeutic concentrations.
Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.
Value and Efficacy of Transcranial Direct Current Stimulation in the Cognitive Rehabilitation: A Critical Review Since 2000.
NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.

Pages